{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:45:30Z","timestamp":1762868730916,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.bioorg.2022.105657","type":"journal-article","created":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T18:12:12Z","timestamp":1644084732000},"page":"105657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Lead optimization and biological evaluation of diazenylbenzenesulfonamides inhibitors against glyoxalase-I enzyme as potential anticancer agents"],"prefix":"10.1016","volume":"120","author":[{"given":"Buthina A.","family":"Al-Oudat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nizar A.","family":"Al-Shar'i","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qosay A.","family":"Al\u2011Balas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suaad A.","family":"Audat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad A.Y.","family":"Alqudah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali H.","family":"Hamzah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramez W.","family":"Hallak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mel","family":"Bedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Bryant-Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2022.105657_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20121743","article-title":"The glyoxalase pathway: the first hundred years\u2026 and beyond","volume":"453","author":"Sousa Silva","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2022.105657_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2690001","article-title":"The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life","volume":"269","author":"Thornalley","year":"1990","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105657_b0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.semcdb.2011.02.013","article-title":"Glyoxalase in ageing","volume":"22","author":"Xue","year":"2011","journal-title":"Semin. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105657_b0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1010632919129","article-title":"Expression of glyoxalase I and II in normal and breast cancer tissues","volume":"66","author":"Rulli","year":"2001","journal-title":"Breast Cancer Res. Treatm."},{"issue":"14","key":"10.1016\/j.bioorg.2022.105657_b0025","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/S0959-8049(02)00236-8","article-title":"Differing expression of enzymes of the glyoxalase system in superficial and invasive bladder carcinomas","volume":"38","author":"Mearini","year":"2002","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.bioorg.2022.105657_b0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0098-2997(93)90002-U","article-title":"The glyoxalase system in health and disease","volume":"14","author":"Thornalley","year":"1993","journal-title":"Mol. Aspects Med."},{"issue":"12","key":"10.1016\/j.bioorg.2022.105657_b0035","doi-asserted-by":"crossref","first-page":"13740","DOI":"10.3390\/molecules171213740","article-title":"Generation of the First Structure-Based Pharmacophore Model Containing a Selective \u201cZinc Binding Group\u201d Feature to Identify Potential Glyoxalase-1 Inhibitors","volume":"17","author":"Al-Balas","year":"2012","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bioorg.2022.105657_b0040","first-page":"83","article-title":"Identification of Possible Glyoxalase II Inhibitors as Anticancer Agents by a Customized 3D Structure-Based Pharmacophore Model Jordan","volume":"8","author":"Al-Shar\u2019i","year":"2015","journal-title":"J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.bioorg.2022.105657_b0045","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10822-019-00226-8","article-title":"Discovery of a nanomolar inhibitor of the human glyoxalase-I enzyme using structure-based poly-pharmacophore modelling and molecular docking","volume":"33","author":"Al-Shar\u2019i","year":"2019","journal-title":"J. Comput.-Aided Mol. Design"},{"issue":"3","key":"10.1016\/j.bioorg.2022.105657_b0050","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00044-019-02486-3","article-title":"Discovery of a nanomolar glyoxalase-I inhibitor using integrated ligand-based pharmacophore modeling and molecular docking","volume":"29","author":"Al-Shar\u2019i","year":"2020","journal-title":"Med. Chem. Res."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105657_b0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/1389557518666181009141231","article-title":"Recent Advances in Glyoxalase-I Inhibition","volume":"19","author":"Al-Balas","year":"2019","journal-title":"Mini-Rev. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2022.105657_b0060","doi-asserted-by":"crossref","DOI":"10.2174\/1570180814666170306120954","article-title":"Novel Thiazole Carboxylic Acid Derivatives Possessing a \u201cZinc Binding Feature\u201d as Potential Human Glyoxalase-I Inhibitors","volume":"14","author":"Al-Balasa","year":"2017","journal-title":"Lett. Drug Des. Discovery"},{"issue":"2","key":"10.1016\/j.bioorg.2022.105657_b0065","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ddr.21421","article-title":"Computational and experimental exploration of the structure\u2013activity relationships of flavonoids as potent glyoxalase-I inhibitors","volume":"79","author":"Al-Balas","year":"2018","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2022.105657_b0070","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.2147\/DDDT.S110997","article-title":"Novel glyoxalase-I inhibitors possessing a \u201czinc-binding feature\u201d as potential anticancer agents","volume":"10","author":"Al-Balas","year":"2016","journal-title":"Drug Design Dev. Therapy"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105657_b0075","article-title":"Design, Synthesis and Biological Evaluation of Potential Novel Zinc Binders Targeting Human Glyoxalase-I; A Validated Target for Cancer Treatment","volume":"11","author":"Al-Balas","year":"2018","journal-title":"Jordan J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105657_b0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2478\/acph-2021-0005","article-title":"Ellagic acid: A potent glyoxalase-I inhibitor with a unique scaffold","volume":"71","author":"Al-Shar\u2019i","year":"2021","journal-title":"Acta Pharm."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105657_b0085","first-page":"225","article-title":"Discovery of Novel Glyoxalase-I Inhibitors Using Computational Fragment-Based Drug Design Approach","volume":"13","author":"Al-Shari","year":"2020","journal-title":"Jordan J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105657_b0090","first-page":"814","article-title":"Combined High Throughput Screening with QSAR Analysis Unravelling Potential Glyoxalase-I Inhibitors","volume":"16","author":"Mahmoud","year":"2020","journal-title":"Curr. Comput.-Aided Drug Design"},{"key":"10.1016\/j.bioorg.2022.105657_b0095","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.compbiolchem.2019.03.011","article-title":"Combination of pharmacophore modeling and 3D-QSAR analysis of potential glyoxalase-I inhibitors as anticancer agents","volume":"80","author":"Al-Sha'er","year":"2019","journal-title":"Comput. Biol. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2022.105657_b0100","doi-asserted-by":"crossref","first-page":"115608","DOI":"10.1016\/j.bmc.2020.115608","article-title":"Design, synthesis and biological evaluation of novel glyoxalase I inhibitors possessing diazenylbenzenesulfonamide moiety as potential anticancer agents","volume":"28","author":"Al-Oudat","year":"2020","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105657_b0105","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0959-440X(96)80061-3","article-title":"Computational methods for biomolecular docking","volume":"6","author":"Lengauer","year":"1996","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105657_b0110","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"issue":"32","key":"10.1016\/j.bioorg.2022.105657_b0115","doi-asserted-by":"crossref","first-page":"22129","DOI":"10.1039\/C6CP03670H","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 6. Capability to predict protein\u2013protein binding free energies and re-rank binding poses generated by protein\u2013protein docking","volume":"18","author":"Chen","year":"2016","journal-title":"PCCP"},{"issue":"3","key":"10.1016\/j.bioorg.2022.105657_b0120","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/1536867X0800800307","article-title":"Speaking Stata: Correlation with confidence, or Fisher's z revisited","volume":"8","author":"Cox","year":"2008","journal-title":"Stata Journal"},{"key":"10.1016\/j.bioorg.2022.105657_b0125","unstructured":"Discovery Studio, Accelrys Inc.: San Diego, CA, USA, 2017."},{"key":"10.1016\/j.bioorg.2022.105657_b0130","unstructured":"Cancer Fact sheet N\u00b0297. 2015 [cited 2015 21 July]; Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs297\/en\/."},{"key":"10.1016\/j.bioorg.2022.105657_b0135","unstructured":"GraphPad Prism 6.01 for Windows, GraphPad Software: La Jolla California USA. p. Calculation and plotting of the % enzyme inhibition and inhibitors IC50's, 2012."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105657_b0140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jcc.10378","article-title":"Performance comparison of generalized born and Poisson methods in the calculation of electrostatic solvation energies for protein structures","volume":"25","author":"Feig","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105657_b0145","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ddr.21421","article-title":"Computational and experimental exploration of the structure\u2013activity relationships of flavonoids as potent glyoxalase-I inhibitors","volume":"79","author":"Al-Balas","year":"2018","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2022.105657_b0150","first-page":"1","article-title":"Novel Thiazole Carboxylic Acid Derivatives Possessing a \u201cZinc Binding Feature\u201d as Potential Human Glyoxalase-I Inhibitors","volume":"14","author":"Al-Balas","year":"2017","journal-title":"Lett. Drug Des. Discov."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822000621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822000621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:30:05Z","timestamp":1758616205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206822000621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":30,"alternative-id":["S0045206822000621"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105657","relation":{},"ISSN":["0045-2068"],"issn-type":[{"type":"print","value":"0045-2068"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lead optimization and biological evaluation of diazenylbenzenesulfonamides inhibitors against glyoxalase-I enzyme as potential anticancer agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105657"}}